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Mental health is a state of psychological and 
emotional well being of an individual. Mental health 
refers to an individual's feeling, thought, and action, 
specifically when a person faces stress and challenges 
in his life. In the present life style, every individual is 
confronted   with  mental   illness.  Neurological   and 
Address for correspondence: 
 
Dr. Pooja Singh 
Post Graduate Scholar, P.G. Department of Agad Tantra, 




Submission Date: 19/07/2021 Accepted Date: 22/08/2021 
Access this article online 
Quick Response Code 
Website: www.jaims.in 
 
Published by Maharshi Charaka 
Ayurveda Organization, Vijayapur, 
Karnataka (Regd) under the license CC-
by-NC-SA 
psychiatric disorders are generally associated with 
memory loss, cognitive deficits, impaired mental 
function, etc. Due to the multi-factorial nature of 
these disease, modern medicine based psychoactive 
drugs have met with limited success. Therefore, there 
is a growing demand for novel products that could 
target multiple pathways and improve mental 
capabilities. According to "Ayurveda," the Indian 
traditional medicine system, "Medhya Rasayana" 
presents herbal therapeutics that boosts memory, 
restore cognitive deficits, and improve mental 
function. Yendri (Bacopa monnieri Family - 
Nyctaginaceae) was used as Ekala Dravya to treat 
mental disorders, particularly those involving anxiety, 
intellect, and poor memory (Singh and Dhawan 1997). 
This review has shown that herbs contain many active 
constituents, including several alkaloids and saponins. 
However, the major components are the steroidal 
saponins, Bacosides A and B, and suggest that they 
influence the cholinergic system. However, recently, it 
A B S T R A C T  
Ayurveda is the life science and practice that involve the care of the human being's physical, mental, 
and spiritual health. The term "Ayu” is defined as- "Sharir Indriya Satva Atma Sanyogo Dhari Jeevtam 
(Charak). According to Acharaya Charaka the individuality of Manas and Sarira is inseparable and 
interdependent. The paragon of the beauty of Ayurveda is that it always emphasizes prevention over 
cure. Yendri (Bacopa monnieri Linn). Mentioned as Medhya by Priyavrat Sharma in his book 
Dravyagun Vigyana. Nowadays, the use of herbal drugs for the treatment of various diseases is 
developing worldwide. Psychiatric and neurological disorders are generally associated with memory 
loss, cognitive deficits, impaired mental function, etc. Due to the multi-factorial nature of these 
diseases, psychoactive drugs of modern medicine have achieved restricted success. Therefore, there is 
an extended stipulation for novel products that could target multiple pathways and improve mental 
capabilities. According to "Ayurveda," the Indian traditional medicine system, "Medhya Rasayana" 
presents herbal therapeutics that restores cognitive deficits, boost memory, and improve mental 
functions. The current review emphasizes the components and application of such type of herbal 
medication. 
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has been reported that Bacopa has an anti-oxidant 
effect in rat frontal cortex, striatum, and hippocampus 
(Bhattacharya et al. 2000). 
The drug profile of Yendri (Bacopa monnieri) is given 
below; 








Satva Guna Bahulya 
Guna Laghu Prakashak 
Rasa  Tikta Medya 
Vipaka Katu Kaph and Tama 
Nashak 
Virya Ushna Dhee, Dhruti, Smriti 







Habit and Habitat  
A small erect herb, commonly growing in marshy 
places throughout India, ascends up to 1500 m. 
Taxonomic classification 
▪ Kingdom - Plantae 
▪ Division - Magnoliophyta 
▪ Class - Magnoliopsida 
▪ Sub class - Asteridae 
▪ Order - Scrophulriales 
▪ Family - Scrophulariaceae 
▪ Genus - Bacopa 
▪ Species - Bacopa monnieri (herb of grace) 
Regional and other Names 
Beng - Udhabini, Brahmi-sak, Dhop-chamni, Jalnimba; 
Eng - Thyme Leaved Gratiola; Guj - Neerbrahmi, 
Bamanevari; Hindi - Brahmi, Jalnim, Safed chamni; 
Kan - Valabrahmi, Oldelaga, Nirubrahmi, 
Mandukaparni; Mal - Brahmi, Nirbrahmi; Mar - 
Jalnam, Bama, Neerbrahmi; Ori - Brahmi; Punj - 
Brahmibuti; Tam - Brahmi, vazhukkai, Piramiyapundu; 
Tel - Sambarani chettu. 
Ayurvedic Description 
Sanskrit name - Brahmi 
Synonyms - Aindri, Jalnimba, Vangiya-Brahmi, 
Lavanika 
Properties  
Rasa - Tikta;  
Guna - Laghu, Sara; 
Virya - Ushna;  
Vipaka - Katu 
Actions - Medhya, Prajasthapna, Rasayna, Swarya, 
Balya. 
Therapeutic uses - Apasmara, Unmada, Kustha, 
Sotha, Mutrakracchra, Masurika. 
Therapeutic uses mentioned in Ayurvedic 
Pharmacopoeia 
The plant is used in Kustha (skin diseases), Jwara 
(fever), Sopha (swelling), Pandu (anemia), Prameha 
(urinary disorders) and Manasa Vikara (psychiatric 
disease). 
Properties and uses ascribed 
The plant is astringent, bitter, cooling, and reported to 
improve intellect. It is used in the asthma treatment, 
hoarseness, insanity, epilepsy, and used as a potent 
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nervine tonic, cardiotonic, diuretic, and skin disease. 
The leaves are useful as diuretic and aperients. The 
leaves juice is given to children in bronchitis and 
diarrhea. The paste of the leaves is used as a remedy 
for rheumatism. Stem and leaves are used in snake 
bites (Nadkarni. 1945; Chopra et al., 1956; the wealth 
of India, 1988). 
Ethnobotanical studies  
The plant is used as an antiepileptic, anti-asthamatic, 
nervine tonic, nootropic, cardiotonic, diuretic and 
aperients, in skin disease, insanity, nervous disorders, 
mental disease and hoarseness. The leaves are used in 
speech disorder, premature ejaculation, in 
rheumatism. The leaves and stem are used as an 
antidote to snake bite. 
Description of the herb 
Bacopa monnieri (BM) is a small, creeping, somewhat 
succulent herb. The leaf and flower-bearing stems are 
10-30 cm long and arise from creeping stems that 
form roots at the nodes. The growth habit of Bacopa, 
therefore, resembles that of peppermint. The leaves 
are simple, obovate-oblong, opposite, approximately 
2 cm × 1 cm, with entire margins, flowers are blue or 
white with purple veins, solitarily on long pedicels in 
the leaf axils. The corollais five-lobed, white or pinkish 
with purple blotches. The fruit is an up to 5 mm 
capsule, which develops in the persistent calyx (Fig. 
1). Bacopa is a member of the family 
Scrophulariaceae.[1,2] 
Macroscopic 
The plant is succulent when fresh but becomes 
shriveled on drying; slightly bitter, without any 
characteristic odor, and composed of crumpled, 
matted broken pieces of roots, branching stems, 
leaves, flowers, and few tender fruits.[3,4] 
Root 
Fragments of dried main roots are cylindrical, about 5 
mm in diameter, longitudinally wrinkled, and off-
white. 
Stem 
Pieces of the stem are cylindrical, glabrous, nodes 
prominent, at places attached with vertically growing 
branches and ventrally to the cluster of tortuous, 
brittle roots, internodes about 1-1.5cm in length and 
3-4mm in diameter, pale yellowish-green and with a 
purplish tinge. 
Leaf 
Simple, opposite and decussate, somewhat sessile, 
glabrous, obovate- oblong to spatulate in shape, 0.6-
2.5cm in length and 3-8mm in width, entire, lower 
surface dotted with minute specks, obscurely 1-3 
nerved, color faint green.[5] 
Flower 
Pale blue or pinkish-white, nearly regular, solitary, 
axillary.  0.6-3 cm in length, usually longer than the 
leaves with two linear bracteoles, pedicel slender, 
calyx glabrous, deeply 5 partite Corolla gamopetalous, 
stamens 4, didynamous, anthers 2 celled, pistil carpel, 
syncarpous ovary two chambered with many ovules, 
style dilated toward the top, stigma-bilobed.[6,7] 
Fruit 
Globose to ovoid, glabrous capsule, 5 mm in length, 
enclosed within persistent calyx, ped 1-3 cm long 
purplish when fresh. 
Seed 




The root is irregularly circular to angular in shape and 
shows an outer most piliferous layer, parenchymatous 
cortex with intervening air spaces and a centrally 
located solid core of xylem encircled by narrow 
phloem. The formation of cork cells replaces the 
piliferous layer, cortex is wide, parenchymatous, 
traversed with simple and compound starch grain 
intervened with air spaces, endodermis is distinct, a 
narrow band of phloem surrounding the located solid 
core of xylem composed of radially arranged isolated 
vessels, fibers, and medullary rays (Fig. 2).[8,9] 
Stem 
The stem is almost circular in outline,  shows outer  
epidermis,  broad aerenchymatous cortex occupying 
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the major area of the section, a distinct endodermis 
encircling the ring of stellar tissue  and central 
parenchymatous pith with a layer of thick-walled 
celled epidermis covered with a thin cuticle, the 
cortex is very wide, consisting of chlorenchymatous 
aerenchyma embedded with starch grains, 
endodermis is distinct, encircling the narrow band of 
parenchymatous phloem and xylem, the central 
region being occupied by narrow parenchymatous 
pith embedded with simple and compound starch 
grains. 
Leaf 
The leaf passing through the midrib is almost 
cylindrical in outline, with a very narrow elevation on 
the midrib's upper side. In the epidermis, the cells of 
the upper being bigger in size and at places show 
striated cuticle, both the epidermis is embedded with 
stomata and bear sessile- glandular trichomes with 
multi cellular head. An arrow collenchymatous band is 
located underneath both the epidermis of the midrib 
and shows a centrally located conjoint collateral 
meristele encircled by a parenchymatous sheath. The 
mesophyll tissue of the lamina is composed of spongy 
parenchyma, traversed with vascular strands; 
prismatic and few cluster crystals of calcium oxalate 
are embedded throughout the parenchymatous cells 
of the leaf.[7,8] 
Powder 
Shows fragments of the upper and lower epidermis of 
leaf in surface view embedded with sessile-glandular 
trichomes with 4-8 celled head and diacytic to 
anomocytic stomata, they being more on the lower 
side, with sinuousanti clinical walls and at places 
shows striated cuticle; prismatic, cluster crystals of 
calcium oxalate, starch grains and oil globules 
scattered as such throughout or embedded in the 
parenchymatous cells, fragments of longitudinally cut 
annular and spiral vessels, transversely cut fragments 
of stem showing aerenchyma to us cortical cells, 
papillose marginal cells of the petal, testa of the seed 




Bacoside A: The chief constituents are brahmine, 
herpestine, alkaloids, and saponins. The saponins 
designated as bacoside A, bacoside B, and betulic acid 
(Figs. 3 and 4). D-mannitol, stigmastanol, β-sitosterol, 
and stigma sterol have been isolated, bacoside A, on 
acid hydrolysis gave three sugars, two of which have 
been identified as glucose and arabinose bacoside B 
also gave on hydrolysis glucose and arabinose.[12] 
Others 
Bacoside   B,   bacoside   A1,   bacoside   A3,    
bacogenin    A1,    bacogenin A2, bacogenin A3, 
bacogenin A4, bacopa saponin-C, bacopasidesIandII, 
bacopasidesIII-V, bacopasidesVI-VIII, bacobitacins A-D, 
monnieraside I, monnieraside III, monnieri, 
plantioside B; jujubogenin, pseudojujubogenin,3-O-β-
D-glucopyranosyl-(l—»3)-[β-D- glucopyranosyl] 
jujubogenin, 3-O-[β-D--glucopyranosyl-(l—»3)-[β-D- 
glucopyranosyl] pseudojujubogenin, betulinic acid, 
wogonin, oroxidin, luteolin, luteolin-7-glucoside, 
luteolin-7-glucuronide, apigenin- 7-glucuronide; 
nicotine, 3-formyl-4-hydroxy-2H-pyran, bacosine, 
bacostcrol, bacosterol-3-O-β-D-glucopyranoside, 
stigmasterol, stigmastanol, β-sitosterol, D-mannitol, 
and an uncharacterized glycoside.[11] 
Quantitative standards[13]  
▪ Foreign matter : Not more than 2.0%.  
▪ Total ash : Not more than 7.0%.  
▪ Acid-insoluble ash : Not more than 2.0%. 
▪ Ethanol soluble extractive : Not <80.0%. 
Preliminary Phytochemical Screening 
The aqueous and ethanolic extract of BM (BME) was 
used for preliminary phytochemical investigation, and 
for the detection of the following metabolites (Table 
2): • Alkaloids • Carbohydrates • Glycosides   
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Table 2: Phytoconstituents present in aqueous 
extract of BM[11,14] 
SN Phytoconstituent Presence/Absence 
1. Tannins -ve 
2. Saponins +ve 
3. Alkaloids -ve 
4. Carbohydrates +ve 
5. Protein +ve 
6. Sterols -ve 
7. Volatile oil -ve 
8. Flavonoids +ve 
9. Triterpenoids +ve 
10. Glycosides +ve 
11. Fixed oil -ve 
+ve : Presence, −ve : Absence, BM : Bacopa monnieri  
▪ Phenolic compounds  
▪ Flavonoids 
▪ Protein and free amino acids 
▪ Saponins  
▪ Sterols. 
Pharmacology 
Ethanol extract (10 mg/kg) brahmi improved motor 
learning in rats. Both ethanol extract as well as the 
active principle hersaponin exhibited tranquilizing 
activity. The active principle also reduced the 
concentration of noradrenaline and 5-
hydroxytryptamine in the brain. Antianxiety effect 
was reported in ethanol extract and saponin in rat. 
Antidepressant activity has also been reported. 
Ethanol extract (50 mg/kg) was found to have 
antigastric ulcer activity in normal and diabetic rats 
and also had anti-Helicobacter pylori activity in vitro. 
Other pharmacological activities reported were anti-
oxidant, anticonvulsant, analgesic, antiallergic, 
antifungal, cardiac depressant, and cardio-tonic either 
by crude extract or pure principle. Major therapeutic 
claims Antileprotic, antiepileptic, antipyretic, 
antidiabetic, anti-inflammatory, and anxiolytic.[15]  
Antiepileptic A clinical study was undertaken with the 
crude aqueous and defatted alcoholic extracts of the 
plant in 24 patients with varied mental disorders. The 
study revealed improvement in learning process and 
correction in the abnormal behavior of epileptic 
patients treated with defatted-alcoholic extract (2-4 
mg/kg b.w.) and crude aqueous extract of "brahmi" 
two dose daily for 5 months. Defatted alcoholic 
extract of "brahmi" was found to be more potent than 
the aqueous form in alleviating the epileptic fits.[16] A 
controlled clinical trial was carried out with crude 
BMEs (4 patients), Marsilea minuta (2 patients), and 
Acorus calamus (6 patients) in epileptic patients with 
special reference to electroencephalography (EEG) 
changes to substantiate their sedative and 
tranquilizing properties. The defatted alcoholic extract 
of "brahmi" showed improvement in one case each of 
temporal lobe epilepsy and petit mal epilepsy. There 
was a close parallelism between the clinical 
improvement and EEG changes in these two cases.[17] 
Antianxiety and antidepressant activity Research 
using a rat model of clinical anxiety demonstrated 
that a BME containing 25% bacoside A showed 
anxiolytic activity comparable to lorazepam (a 
common benzodiazepine anxiolytic drug), and it was 
attentively noted that the BME did not induce 
amnesia, side effects associated with lorazepam, but 
instead had a memory-enhancing effect.[18] The 
antidepressant potential study of BM showed 
significant antidepressant effect in the most 
commonly used behavior paradigms in animal models 
of depression, such as forced swim test and learned 
helplessness tests. In the study, of 20-40 mg/kg dose 
of BME was given for 5 days once in a day, and it was 
found comparable to standard antidepressant drug 
imipramine. The same study has showed the role of 
serotonin and gamma amino butyric acid (GABA) in 
the mechanism of action accredited for its 
antidepressant effect with its anxiolytic potential, 
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based on the captivating evidence that the symptoms 
of anxiety and depression overlap each other.[19]  
Memory enhancer Efficacy of plant was studied in 
revitalizing intellectual functions in 40 school going 
children from rural area in Varanasi. One group was 
given "brahmi" syrup one teaspoon full (350 mg), 
thrice daily for 3 months, and the other group was 
given syrup "simplex" used as placebo in the same 
dose. There were renovation and improvement of the 
perceptual-motor functions during the development 
phase in the group receiving "brahmi." A double-blind 
controlled study was carried out to evaluate the effect 
of a micro ("suksma") medicine derived from the plant 
by 1 month treatment on 110 boy students in the age 
of 10- 13 years and having average IQ 100. The study 
showed encouraging results in enhancing some 
factors of intelligence, viz., memory (direct), 
arithmetic skill, and some verbal factors. Need for 
long-term study was felt.[20] 
Sedative and tranquilizing properties earlier studies 
reported a sedative effect of glycosides named 
hersaponins. A subsequent study on albino rats and 
dogs showed that the alcoholic and aqueous extract 
of plants exhibited tranquilizing effects. On the other 
hand, study showed that the alcoholic extract of the 
plant and chlorpromazine improved the performance 
of rats in motor learning. An earlier research showed 
that a single dose of the glycoside, hersaponin, is 
better than the drug pentobarbitone in facilitating 
acquisition and retention of brightness discrimination 
reaction.[21] 
The effect of Brahmi Rasayan, an ayurvedic 
preparation, was studied in mice and rats for its 
effects on the central nervous system at 1 and 30 g/kg 
oral dose. Observational screening in mice was taken 
following the multiparametric check list. It was 
studied for its effect on pentobarbitone hypnosis, 
motor coordination, reaction time, tail withdraws 
haloperidol-induced catalepsy, electroshock, 
chemoconvulsions, and conditioned avoidance 
response. It exhibited a sedative effect and 
remarkably extended the hypnotic action.  It also 
produced a variable blockade of conditioned 
avoidance response. The chemoconvulsions, ability to 
antagonize the haloperidol-induced catalepsy, 
presence of a significant antinoclceptive effect, along 
with the ability to offer protection against 
electroshock seizures, suggests an involvement of the 
GABAergic system in the Brahmi Rasayan's effect on 
CNS.[22]  
Anti-oxidant and adaptogenic properties BME or 
bacosides have shown an anti-oxidant activity and 
antistress.[21] An earlier study suggests an involvement 
of the GABAergic system in the mediation of these 
central nervous system effects of BM.[22] Based on 
animal study, bacosides were shown to have anti-
oxidant activity in the hippocampus, frontal cortex, 
and striatum.[23] Animal studies shown that the BMEs 
change the expression of certain enzymes that are 
involved in generating and scavenging of reactive 
oxygen species (ROS) in the brain.[24] In another study, 
BME was found not only to induce the constitute 
expression of heat-shock protein 70 (Hsp70) but also 
induce the cytochrome P450 (CYP 450) enzymes in all 
regions of the brain. The level of heat shock protein 
Hsp70 was found to be increased in the brain as a 
response of stress condition. On the other hand, the 
group that was pre-treated for 1 week with 20-40 
mg/kg/daily dose of BM, before giving stress, the 
protein Hsp70 was in lower concentration. An 
increase in CYP 450-dependent enzymes 7-
pentoxyresorufin-odealkkylase and 7-ethoxyresorufin-
o-deethylase activity was observed in all the brain 
regions after exposure to stress alone and with both 
doses of BME although the magnitude of induction 
observed was less with a higher dose of the same. 
Thus, it was suggested that the BM primed the brain 
for stress by stockpiling these useful enzymes even 
before stressful conditions and that our susceptibility 
to stress could be lowered by using this medicinal 
herb. It was speculated that this induction may be an 
adaptive response to the stress which needs further 
investigation. The level of superoxide dismutase (SOD) 
was also increased in the brain in the groups pre-
treated with BME. The data indicated that BME has a 
potential to modulate the activities of Hsp70, CYP 
450, and SOD and thereby possibly allowing the brain 
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to be prepared to act under adverse condition-like 
stress.[25] 
Endocrine effects BME (200 mg/kg orally) increased 
the thyroid hormone, T4, by 41% in mice. T3 was not 
stimulated, suggesting that the extract may directly 
stimulate synthesis and/or release of T4 at the 
glandular level while not affecting conversion of T4 to 
T3 [26]. BMEs caused reversible suppression of 
spermatogenesis and fertility. The treatment caused 
reduction in motility and viability of the sperms and 
reduced the number of spermatozoa in cauda 
epididymis and testis, and caused alterations in the 
somniferous tubules in mice.[26]  
The alcoholic extract of the BM whole plant on 
morphine withdrawal was evaluated in vitro in 
guinea-pig ileum. After 4 minutes, in vitro exposure to 
morphine, addition of naloxone-induced a strong 
contraction condition. Addition of different alcoholic 
BM concentrations, (100-1000 μg/ml), 15 minutes 
before exposure to morphine, has reduced the 
naloxone-induced contraction in a dose-dependent 
manner. The results suggest that BM extract may be 
useful in reducing the withdrawal symptoms induced 
by morphine.[27] 
Free radical scavenging effects. The free radical 
scavenging capacity of a methanolic BM extract, and 
the effect on DNA cleavage induced by H202 
ultraviolet-photolysis was investigated. In addition, it 
is examined whether this plant extract is capable of 
reducing the hydrogen peroxide-induced cytotoxicity 
and DNA damage in human non-immobilized 
fibroblasts. It showed a dose-dependent effect on free 
radical scavenging, and a protective effect on DNA 
cleavage. The results were confirmed by a significant 
protective effect on H2O2 - induced cytotoxicity and 
DNA damage in human non-immortalized fibroblasts.  
Cigarette smoking is considered as a major factor in 
the development of cardiovascular and 
cerebrovascular diseases. Creatine kinase (CK), and its 
isoforms have beer advocated as sensitive markers in 
the assessment of cardiac and cerebral damage. 
Therefore, in the present study, it reports the 
isoenzyme patterns of CK in rats on exposure to 
smoke and the protective effect of bacoside against 
chronic smoking-induced toxicity. Adult male albino 
rats were exposed to cigarette smoke and 
simultaneously administered with bacoside A, the 
active constituent from the plant BM, for a period of 
12-week the activity of CK was assayed in serum, 
heart, and brain, and its isoenzymes in serum were 
separated electrophoretically. Rats exposed to 
cigarette smoke showed a significant increase in 
serum CK activity with concomitant decrease in heart 
and brain also cigarette smoke exposure resulted in a 
marked increase in all the three isoforms in serum. 
Administration of bacoside a prevented these 
alterations induced by cigarette smoking, cigarette 
smoking is known to cause free radical mediated lipid 
peroxidation (LPO) leading to increased membrane 
permeability and cellular damage in the heart and 
brain resulting in the release of CK into the circulation 
the protective effect of bacoside on the structural and 
functional integrity of the membrane prevented the 
leakage of CK from the respective tissues, which could 
he attributed to its free radical scavenging and 
antilipid peroxidative effect.[29]  
Hair growth promoting activity Herbal hair oil 
formulated from Emblica officinalis, BM, and Cyperus 
rotundus alcoholic extract or as a whole drug. The hair 
oil was prepared individually, and a mixture of fixed 
proportion of all the three herbs using coconut oil as a 
base. The formulated oil was evaluated physical, 
chemical, and hair growth properties of formulated oil 
by applying it topically on shaved skin of albino rats. 
Primary skin irritation test and hair length test were 
performed, and the hair growth was compared with 
standard minoxidil 2% ethanolic solution using 
healthy albino rats. It was observed that hair oil 
formulation showed the best result among the other 
formulation evaluated by showing an enlargement of 
follicular size and prolongation of the anagen 
phase.[30,32] 
Antimicrobial effect the antibacterial activity of BM 
was screened for different bacterial strains using 
methanol, ethanol, chloroform, and petroleum ether. 
The phytochemical screening was carried out to know 
the compounds responsible for these activities. 
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Methanol, ethanol, and chloroform extracts were 
tested against Bacillus amyloliquefaciens (MTCC 
1270), Streptococcus pyogens (MTCC 1923), Vulgarica, 
Bacillus megaterium (MTCC 3353), Aspergillus niger 
(MTCC 281), Bacillus pumilus, Salmonella typhi, 
Bacillus subtilis, and Micrococcus luteus. The 
susceptibility of the bacteria to the crude extracts on 
the basis of zones of growth inhibition varied 
according to microorganism and extracting solvent. In 
most of the above-mentioned plants, the methanol 
extract produced the highest activity. On the basis of 
the results obtained, it could be concluded that 
methanol could be used for extracting antimicrobial 
compounds from leaves.[33]  
Gastrointestinal affects some in vitro, animal and 
human studies have investigated the effects of BME 
on the gastrointestinal tract. In vitro studies have 
demonstrated direct spasmolytic activity on intestinal 
smooth muscle, via inhibition of calcium influx across 
cell membrane channels. This property suggests that 
BME may be of benefit in conditions characterized by 
intestinal spasm such as irritable bowel 
syndrome.[34,35] The results indicated the direct action 
of the extract on smooth muscles. Furthermore, 
calcium chloride-induced responses observed in the 
rabbits' blood vessels and jejunum were reduced in 
the presence of the BME (10- 700 mcg/mL), 
suggesting direct interference with the influx of 
calcium ions. However, since the extract did not affect 
contractions induced by noradrenalin or caffeine, the 
authors concluded that the extract had no appreciable 
effect on the mobilization of intracellular calcium. 
Based on the results of the experiment, it is 
postulated that the spasmolytic effect of BME on 
smooth muscles is predominantly due to the 
inhibition of calcium influx, applicable to both 
electrical impulse-mediated and receptor-mediated 
calcium channels in the cell membrane. Animal and in 
vitro studies suggested that BM may have a protective 
and curative effect on gastric ulcers, and studies were 
reported for its antiulcerogenic activity.[35,36] In rats, a 
BME standardized for bacoside A was evaluated for its 
prophylactic and healing effects in five models of 
gastric ulcers .[37] At a dose of 20 mg/kg for 10 days, 
BME significantly healed penetrating ulcers induced 
by acetic acid, significantly strengthened the mucosal 
barrier and decreased mucosal exfoliation. The 
extract also alleviated stress-induced ulcers as 
observed by a significant reduction in LPO in rat 
gastric mucosa. BM's anti-oxidant properties and its 
ability to balance SOD and catalase levels were 
postulated to account for this effect. A recent in vitro 
study also incubated with human colonic mucosal 
cells and H. pylori, it resulted in the accumulation of 
prostaglandin E and prostacyclin, prostaglandins 
known to be protective for gastric mucosa. 
Anticonvulsant Crude plant extract of BM or bacosides 
has also shown anticonvulsive action. It possessed 
neuroprotective effects in glutamate-mediated 
excitotoxicity during seizures and cognitive damage 
occurring in association with pilocarpine-induced 
epilepsy. The ethanolic extract of BM was tested for 
anticonvulsant activity using different convulsive 
models (pentylenetetrazol, maximal electroshock, and 
strychnine-induced convulsion in rats, as well as 
hypoxic stress induced convulsions in mice and 
lithium-pilocarpine-induced status epilepticus). The 
ethanolic extract of BM was administered as 50-55 
mg/kg orally for rats and mice, respectively, 2 and 4 
hrs before the respective convulsive stimuli. The 
ethanolic extract of leaves produced significant 
anticonvulsant activity for all the different models 
studied with a mechanism of action similar to that of 
benzodiazepines (GABA agonist).[16,18] 
Safety aspects: The drug used in traditionally 
prescribed doses may be considered safe. 
Dose Powder: 1-3 g.  
CONCLUSION 
This present review article contains spectrum of 
information about Bacopa monnieri under major 
heads general information, pharmacognostic, 
chemical, pharmacological, clinical studies with 
references. 
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